Nordion is a global health science company that provides market-leading products used for the prevention, diagnosis and treatment of disease. We are a leading provider of targeted therapies, sterilization technologies and medical isotopes that benefit the lives of millions of people in more than 60 countries around the world. Learn more >
Customers use our gamma sterilization technologies to sterilize medical surgical supplies and devices, as well as certain consumer products, such as food and cosmetics.
Nordion produces a comprehensive range of medical isotope products for imaging used to diagnose heart disease and various forms of cancer.
TheraSphere® (radioembolization) is a low toxicity, targeted liver cancer therapy that consists of millions of tiny glass beads containing radioactive yttrium-90, delivered directly to liver tumors.
Latest NewsMay 23: Nordion Enters into Agreement to Divest Targeted Therapies Business to BTG plc May 16: Medical Isotopes Supply Update – AECL National Research Universal (NRU) Reactor Restart May 15: Nordion Signs Contract Manufacturing Agreement with Navidea Biopharmaceuticals Upcoming Events |
Stock QuoteTSX:NDN PRICE: $ NYSE:NDZ PRICE: $ |
Follow Nordion     
|
